![](/img/cover-not-exists.png)
MA 19.03 Nintedanib + Pemetrexed/Cisplatin in Malignant Pleural Mesothelioma (MPM): Phase II Biomarker Data from the LUME-Meso Study
Nowak, A., Grosso, F., Steele, N., Novello, S., Popat, S., Greillier, L., John, T., Leighl, N., Reck, M., Pavlakis, N., Sørensen, J.B., Planchard, D., Ceresoli, G., Hughes, B., Mazieres, J., Socinski,Volume:
12
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2017.09.636
Date:
November, 2017
File:
PDF, 182 KB
english, 2017